Summary
For Year 2026-27, Onesource Specialty Pharma reports the following shareholding: Total Promoters at 30.48%, Mutual Fund at 10.13%, Insurance at 3.35%, Foreign Institutional Investors at 17.5%, Domestic Institutional Investors at 7.13%, and Retail at 31.41%. This breakdown provides a quick snapshot of ownership distribution for Onesource Specialty Pharma in 2026-27.
Onesource Specialty Pharma FAQs
As of 04-2026, the promoter shareholding in Onesource Specialty Pharma stands at 30.48% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Onesource Specialty Pharma is 17.5% and 7.13% respectively.
The retail shareholding of the Onesource Specialty Pharma is 31.41%.
Changes in shareholding patterns of Onesource Specialty Pharma can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Onesource Specialty Pharma are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
Onesource Specialty Pharma Associated Pages
- Onesource Specialty Pharma Share Price
- Onesource Specialty Pharma Share Price chart
- Onesource Specialty Pharma Fundamental Analysis
- Onesource Specialty Pharma Technical Analysis
- Onesource Specialty Pharma Peer Comparison
- Onesource Specialty Pharma Share Price History
- Onesource Specialty Pharma Board of Directors
